Amphotericin B encapsulated in polyethylene glycol-immunoliposomes for infectious diseases

Advanced Drug Delivery Reviews

Volumn 24, Issue 2-3, 1997, Pages 325-329

  Kohno, Shigeru ^a   Otsubo, Takakazu ^a   Tanaka, Eitaro ^b   Maruyama, Kazuo ^b   Hara, Kohei ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

amphotericin B; antifungal agent; immunoliposome; long circulating liposome; mycosis; pulmonary aspergillosis

Indexed keywords

ANTIBIOTICS; ANTIBODIES; BIOMEDICAL ENGINEERING; CHEMICAL MODIFICATION; DRUG PRODUCTS; ENCAPSULATION; IMMUNOLOGY; LIPIDS; PHARMACOKINETICS; POLYETHYLENE GLYCOLS;

AMPHOTERICIN; ANTIFUNGAL AGENT; IMMUNOLIPOSOME; LIPOSOME; MONOCLONAL ANTIBODY; MYCOSIS; PULMONARY ASPERGILLOSIS; RETICULO ENDOTHELIAL SYSTEM; THERAPEUTIC EFFICACY;

DRUG THERAPY;

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CHOLESTEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHATIDYLETHANOLAMINE; IMMUNOLIPOSOME; MACROGOL; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 34A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CIRCULATION TIME; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TARGETING; DRUG TISSUE LEVEL; ENCAPSULATION; EXPERIMENTAL INFECTION; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LIVER; LUNG ASPERGILLOSIS; LUNG ENDOTHELIUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; TISSUE DISTRIBUTION;

EID: 0343051794     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(96)00474-7     Document Type: Conference Paper

References (14)

1. Graybill, J.R., Craven, P.C., Taylor, R.L., Williams, D.M. and Maree, W.E. (1982) Treatment of murine cryptococcosis with liposomal-associated amphotericin B. J. Infect. Dis., 145, 748-752.
2. Jullien, S., Brajburg J. and Bolard, J. (1990) Affinity of amphotericin B for phosphatidylcholine vesicles as a determinant of the in vitro cellular toxicity of liposomal preparations. Biochim. Biophys. Acta, 1021, 39-45.
3. Krause, H.J. and Juliano, R.L. (1988) Interactions of liposome-incorporated amphotericin B with kidney epithelial cell cultures. Mol. Pharmacol., 34, 286-297.
4. Lopez-Berestein, G., Mehta, R., Hopfer, R.L., Mills, K., Kasi, L., Mehta, K., Fainstein, V., Luna, M., Hersh, E.M. and Juliano, R.L. (1983) Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J. Infect. Dis., 147, 939-945.
5. van Etten, E.W.M., Otte-Lambillion, M., van Vianen, W., ten Kate, M.T. and Bakker-Woudenberg, I.A.M. (1995) Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans. J. Antimicrob. Chemother., 35, 509-519.
6. Wassan, K.M., Vadiel, K., Lopez-Berestein, G. and Luke, D.R. (1990) Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats. J. Infect. Dis., 161, 562-566.
7. Maruyama, K., Holmberg, E., Kennel, S.J., Klibanov, A., Torchilin, V.P. and Huang, L. (1990) Characterization of in vivo immunoliposome targeting to pulmonary endothelium. J. Pharm. Sci., 79, 978-984.
8. Klibanov, A.L., Maruyama, K., Beckerleg, A.M., Torchilin, V.P. and Huang, L. (1991) Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim. Biophys. Acta, 1062, 142-148.
9. Maruyama, K., Takizawa, T., Yuda, T., Kennel, S.J., Huang, L. and Iwatsuru, M. (1995) Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminal to monoclonal antibodies. Biochim. Biophys. Acta, 1234, 74-80.
10. Hughes, B.J., Kennel, S., Lee, R. and Huang, L. (1989) Monoclonal antibody targeting of liposomes to mouse lung in vivo. Cancer Res., 49, 6214-6220.
11. Kennel, S.J., Lankford, T., Hughes, B., Hotchkiss, J.A. (1988) Quantitation of a murine lung endothelial cell protein, P112, with a double monoclonal antibody assay. J. Lab. Invest., 59, 692-701.
12. Maruyama, K., Okamoto, A., Ishida, O., Kojima, S., Suginaka, A., Huang, L. and Iwatsuru, M. (1994) Biodistribution and antitumor effect of adriamycin encapsulated in long-circulating liposomes containing amphipathic polyethylene glycol or ganglioside GM1. J. Liposome Res., 4.
13. Ringden, O., Meunier, F., Tollemar, J., Ricci, P., Tura, S., Kuse, E., Viviani, M.A., Gorin, N.C., Klastersky, J., Fenaux, P., Prentice, H.G. and Ksionski, G. (1991) Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. J. Antimicrob. Chemother., 28, Suppl. B, 73-82.
14. Hay, R.J. (1994) Liposomal amphotericin B, AmBisome. J. Infect., 28, Suppl. I, 35-43.